Shares of Texas Instruments (TXN) Move Up on Q1 Earnings Report; CEO Saw Business Cycle Bottom
Tweet
Share
E-mailGet Alerts TXN Hot Sheet
Price: $173.57 -0.71%
EPS Growth %: -40.5%
Financial Fact:
Gross profit: 2.28B
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -40.5%
Financial Fact:
Gross profit: 2.28B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Shares of Texas Instruments (NYSE: TXN) are trading up 2.63% to $32.70 in after-hours. The company reported Q1 EPS of $0.22, 5 cents above the analyst estimate of $0.17. Revenues were $3.12 billion versus the consensus estimate of $3.06 billion.
TXN issues in-line guidance, but the range slightly favors upside, including: Seeing Q2 2012 EPS of $0.30-$0.38, vs. the consensus of $0.32. TXN sees Q2 2012 revenue of $3.22-$3.48 bln vs. the consensus of $3.29 bln.
"As we expected, our business cycle bottomed in the first quarter, and early signs of growth began to emerge," said Rich Templeton, TI's chairman, president and CEO. "Orders were up 13 percent, and backlog is growing again. Particularly encouraging is the breadth of increased orders across geographical regions and markets, including the industrial sector.
For the full year of 2012, TI continues to expect approximately the following: 1) R&D expense: $2.0 billion; 2) Capital expenditures: $0.7 billion; 3) Depreciation: $1.0 billion; and 4) Annual effective tax rate: 28%
TXN issues in-line guidance, but the range slightly favors upside, including: Seeing Q2 2012 EPS of $0.30-$0.38, vs. the consensus of $0.32. TXN sees Q2 2012 revenue of $3.22-$3.48 bln vs. the consensus of $3.29 bln.
"As we expected, our business cycle bottomed in the first quarter, and early signs of growth began to emerge," said Rich Templeton, TI's chairman, president and CEO. "Orders were up 13 percent, and backlog is growing again. Particularly encouraging is the breadth of increased orders across geographical regions and markets, including the industrial sector.
For the full year of 2012, TI continues to expect approximately the following: 1) R&D expense: $2.0 billion; 2) Capital expenditures: $0.7 billion; 3) Depreciation: $1.0 billion; and 4) Annual effective tax rate: 28%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbus revenue rises, delivers 142 commercial aircraft in Q1
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- CEMEX, S.A.B. de C.V. (CX) Tops Q1 EPS by 5c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
